Oxandrolone use in Crohn's disease.
Kravetz
J D
JD
Lee
C
C
Dieterich
D T
DT
D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D015992:Body Mass Index; D003424:Crohn Disease / Q000188:drug therapy* / Q000503:physiopathology; D017097:Electric Impedance; D004734:Energy Metabolism / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D010074:Oxandrolone / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use; D015431:Weight Loss / Q000187:drug effects
D045930:Anabolic Agents; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D010074:Oxandrolone; D011241:Prednisone